Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1

Stephen N Thibodeau, Amy J. French, Julie M Cunningham, David Tester, Lawrence J. Burgart, Patrick C. Roche, Shannon K. McDonnell, Daniel J Schaid, Catherine Walsh Vockley, Virginia V. Michels, Gist H. Farr, Michael J. O'Connell

Research output: Contribution to journalArticle

463 Citations (Scopus)

Abstract

Recent studies have demonstrated the presence of microsatellite instability (MSI) in tumors from patients with hereditary nonpolyposis colorectal cancer and in a large number of sporadic tumors. To further characterize the type of alterations at these loci and their frequency of involvement in colon cancer, we studied DNA extracted from paraffin-embedded tissue from 508 patients using 11 microsatellites localized to chromosomes 5, 8, 15, 17, and 18. Overall, MSI at each locus varied in character and frequency and was observed with at least one marker in 191 cases (37.6%). Based on the number of markers displaying instability per tumor, three groups of patients were defined: those with <30% of the markers showing instability (MSI-L, n = 109, 21.5%); those with ≤30% (MSI-H, n = 82, 16.1%); and those showing no instability (MSS, n = 317, 62.4%). These groups were tested for correlations with a number of clinical and pathological parameters, including age, sex, stage, ploidy status, and site of tumor. Comparing across the three groups and verified by pair-wise comparisons, the MSI-H group was associated with tumor site (proximal colon, P = 0.001), sex (females, P = 0.005), stage (Dukes' B, P = 0.01), and ploidy status (diploid, P = 0.03). No significant differences were noted between the MSI-L and MSS group for any of the parameters tested. An additional 188 consecutive surgical colorectal cancer cases were examined for the presence of MSI and for the immunohistochemical expression of hMLH1 and hMSH2 proteins. Of this group, 129 (68.6%) were classified as MSS, 17 (9.0%) as MSI-L, and 42 (22.3%) as MSI-H. None of the MSS and none of the MSI-L tumors had altered expression of either hMLH1 or hMSH2. However, the majority of MSI-H (40 of 42, 95%) cases demonstrated absence of staining for these proteins. The most frequently altered protein was hMLH1, occurring in 95% of the tumors with altered expression. Cumulatively, these data suggest that the tumor phenotype MSI-H is distinct from tumor phenotypes MSI-L and MSS, with no apparent differences between MSI-L and MSS. Furthermore, altered hMLH1 protein expression appears to be responsible for the mutator phenotype in the vast majority of MSI-H tumors.

Original languageEnglish (US)
Pages (from-to)1713-1718
Number of pages6
JournalCancer Research
Volume58
Issue number8
StatePublished - Apr 15 1998

Fingerprint

Microsatellite Instability
Colorectal Neoplasms
Phenotype
Neoplasms
Ploidies
Proteins
Hereditary Nonpolyposis Colorectal Neoplasms
Chromosomes, Human, Pair 8
Chromosomes, Human, Pair 5
Diploidy
Paraffin
Microsatellite Repeats
Colonic Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Microsatellite instability in colorectal cancer : Different mutator phenotypes and the principal involvement of hMLH1. / Thibodeau, Stephen N; French, Amy J.; Cunningham, Julie M; Tester, David; Burgart, Lawrence J.; Roche, Patrick C.; McDonnell, Shannon K.; Schaid, Daniel J; Vockley, Catherine Walsh; Michels, Virginia V.; Farr, Gist H.; O'Connell, Michael J.

In: Cancer Research, Vol. 58, No. 8, 15.04.1998, p. 1713-1718.

Research output: Contribution to journalArticle

Thibodeau, SN, French, AJ, Cunningham, JM, Tester, D, Burgart, LJ, Roche, PC, McDonnell, SK, Schaid, DJ, Vockley, CW, Michels, VV, Farr, GH & O'Connell, MJ 1998, 'Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1', Cancer Research, vol. 58, no. 8, pp. 1713-1718.
Thibodeau, Stephen N ; French, Amy J. ; Cunningham, Julie M ; Tester, David ; Burgart, Lawrence J. ; Roche, Patrick C. ; McDonnell, Shannon K. ; Schaid, Daniel J ; Vockley, Catherine Walsh ; Michels, Virginia V. ; Farr, Gist H. ; O'Connell, Michael J. / Microsatellite instability in colorectal cancer : Different mutator phenotypes and the principal involvement of hMLH1. In: Cancer Research. 1998 ; Vol. 58, No. 8. pp. 1713-1718.
@article{46e7df1e67ff4b568fddd286dfa87f2b,
title = "Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1",
abstract = "Recent studies have demonstrated the presence of microsatellite instability (MSI) in tumors from patients with hereditary nonpolyposis colorectal cancer and in a large number of sporadic tumors. To further characterize the type of alterations at these loci and their frequency of involvement in colon cancer, we studied DNA extracted from paraffin-embedded tissue from 508 patients using 11 microsatellites localized to chromosomes 5, 8, 15, 17, and 18. Overall, MSI at each locus varied in character and frequency and was observed with at least one marker in 191 cases (37.6{\%}). Based on the number of markers displaying instability per tumor, three groups of patients were defined: those with <30{\%} of the markers showing instability (MSI-L, n = 109, 21.5{\%}); those with ≤30{\%} (MSI-H, n = 82, 16.1{\%}); and those showing no instability (MSS, n = 317, 62.4{\%}). These groups were tested for correlations with a number of clinical and pathological parameters, including age, sex, stage, ploidy status, and site of tumor. Comparing across the three groups and verified by pair-wise comparisons, the MSI-H group was associated with tumor site (proximal colon, P = 0.001), sex (females, P = 0.005), stage (Dukes' B, P = 0.01), and ploidy status (diploid, P = 0.03). No significant differences were noted between the MSI-L and MSS group for any of the parameters tested. An additional 188 consecutive surgical colorectal cancer cases were examined for the presence of MSI and for the immunohistochemical expression of hMLH1 and hMSH2 proteins. Of this group, 129 (68.6{\%}) were classified as MSS, 17 (9.0{\%}) as MSI-L, and 42 (22.3{\%}) as MSI-H. None of the MSS and none of the MSI-L tumors had altered expression of either hMLH1 or hMSH2. However, the majority of MSI-H (40 of 42, 95{\%}) cases demonstrated absence of staining for these proteins. The most frequently altered protein was hMLH1, occurring in 95{\%} of the tumors with altered expression. Cumulatively, these data suggest that the tumor phenotype MSI-H is distinct from tumor phenotypes MSI-L and MSS, with no apparent differences between MSI-L and MSS. Furthermore, altered hMLH1 protein expression appears to be responsible for the mutator phenotype in the vast majority of MSI-H tumors.",
author = "Thibodeau, {Stephen N} and French, {Amy J.} and Cunningham, {Julie M} and David Tester and Burgart, {Lawrence J.} and Roche, {Patrick C.} and McDonnell, {Shannon K.} and Schaid, {Daniel J} and Vockley, {Catherine Walsh} and Michels, {Virginia V.} and Farr, {Gist H.} and O'Connell, {Michael J.}",
year = "1998",
month = "4",
day = "15",
language = "English (US)",
volume = "58",
pages = "1713--1718",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Microsatellite instability in colorectal cancer

T2 - Different mutator phenotypes and the principal involvement of hMLH1

AU - Thibodeau, Stephen N

AU - French, Amy J.

AU - Cunningham, Julie M

AU - Tester, David

AU - Burgart, Lawrence J.

AU - Roche, Patrick C.

AU - McDonnell, Shannon K.

AU - Schaid, Daniel J

AU - Vockley, Catherine Walsh

AU - Michels, Virginia V.

AU - Farr, Gist H.

AU - O'Connell, Michael J.

PY - 1998/4/15

Y1 - 1998/4/15

N2 - Recent studies have demonstrated the presence of microsatellite instability (MSI) in tumors from patients with hereditary nonpolyposis colorectal cancer and in a large number of sporadic tumors. To further characterize the type of alterations at these loci and their frequency of involvement in colon cancer, we studied DNA extracted from paraffin-embedded tissue from 508 patients using 11 microsatellites localized to chromosomes 5, 8, 15, 17, and 18. Overall, MSI at each locus varied in character and frequency and was observed with at least one marker in 191 cases (37.6%). Based on the number of markers displaying instability per tumor, three groups of patients were defined: those with <30% of the markers showing instability (MSI-L, n = 109, 21.5%); those with ≤30% (MSI-H, n = 82, 16.1%); and those showing no instability (MSS, n = 317, 62.4%). These groups were tested for correlations with a number of clinical and pathological parameters, including age, sex, stage, ploidy status, and site of tumor. Comparing across the three groups and verified by pair-wise comparisons, the MSI-H group was associated with tumor site (proximal colon, P = 0.001), sex (females, P = 0.005), stage (Dukes' B, P = 0.01), and ploidy status (diploid, P = 0.03). No significant differences were noted between the MSI-L and MSS group for any of the parameters tested. An additional 188 consecutive surgical colorectal cancer cases were examined for the presence of MSI and for the immunohistochemical expression of hMLH1 and hMSH2 proteins. Of this group, 129 (68.6%) were classified as MSS, 17 (9.0%) as MSI-L, and 42 (22.3%) as MSI-H. None of the MSS and none of the MSI-L tumors had altered expression of either hMLH1 or hMSH2. However, the majority of MSI-H (40 of 42, 95%) cases demonstrated absence of staining for these proteins. The most frequently altered protein was hMLH1, occurring in 95% of the tumors with altered expression. Cumulatively, these data suggest that the tumor phenotype MSI-H is distinct from tumor phenotypes MSI-L and MSS, with no apparent differences between MSI-L and MSS. Furthermore, altered hMLH1 protein expression appears to be responsible for the mutator phenotype in the vast majority of MSI-H tumors.

AB - Recent studies have demonstrated the presence of microsatellite instability (MSI) in tumors from patients with hereditary nonpolyposis colorectal cancer and in a large number of sporadic tumors. To further characterize the type of alterations at these loci and their frequency of involvement in colon cancer, we studied DNA extracted from paraffin-embedded tissue from 508 patients using 11 microsatellites localized to chromosomes 5, 8, 15, 17, and 18. Overall, MSI at each locus varied in character and frequency and was observed with at least one marker in 191 cases (37.6%). Based on the number of markers displaying instability per tumor, three groups of patients were defined: those with <30% of the markers showing instability (MSI-L, n = 109, 21.5%); those with ≤30% (MSI-H, n = 82, 16.1%); and those showing no instability (MSS, n = 317, 62.4%). These groups were tested for correlations with a number of clinical and pathological parameters, including age, sex, stage, ploidy status, and site of tumor. Comparing across the three groups and verified by pair-wise comparisons, the MSI-H group was associated with tumor site (proximal colon, P = 0.001), sex (females, P = 0.005), stage (Dukes' B, P = 0.01), and ploidy status (diploid, P = 0.03). No significant differences were noted between the MSI-L and MSS group for any of the parameters tested. An additional 188 consecutive surgical colorectal cancer cases were examined for the presence of MSI and for the immunohistochemical expression of hMLH1 and hMSH2 proteins. Of this group, 129 (68.6%) were classified as MSS, 17 (9.0%) as MSI-L, and 42 (22.3%) as MSI-H. None of the MSS and none of the MSI-L tumors had altered expression of either hMLH1 or hMSH2. However, the majority of MSI-H (40 of 42, 95%) cases demonstrated absence of staining for these proteins. The most frequently altered protein was hMLH1, occurring in 95% of the tumors with altered expression. Cumulatively, these data suggest that the tumor phenotype MSI-H is distinct from tumor phenotypes MSI-L and MSS, with no apparent differences between MSI-L and MSS. Furthermore, altered hMLH1 protein expression appears to be responsible for the mutator phenotype in the vast majority of MSI-H tumors.

UR - http://www.scopus.com/inward/record.url?scp=0032522658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032522658&partnerID=8YFLogxK

M3 - Article

C2 - 9563488

AN - SCOPUS:0032522658

VL - 58

SP - 1713

EP - 1718

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 8

ER -